Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
8223483
Reference Type
Journal Article
Title
Derivatization of artemisinin derivatives using 4-carboxyl -2, 6-dinitro benzenediazonium (CDNBD) ion
Author(s)
Adegoke, OA; Idowu, OS; Daramola, OP; Ogunsanya, OS
Year
2010
Volume
52
Issue
3
Page Numbers
269-280
Language
English
Abstract
A new UV-spectrophotometric method for analysis of artesunate, dihydroartemisinin and artemether has been developed. The reaction involves the diazo coupling of acid decomposition product generated in situ with the highly reactive 4- carboxyl-2,6- dinitrobenzene diazonium ion (CDNBD) to form azo adducts that are UV active. Optimum reaction conditions were established at 70oC for 10 min (artesunate and artemether) and 5 min (dihydroartemisinin). The diazotized compounds were determined at λ max of 320 nm (artesunate and dihydroartemisinin) and 310 nm (artemether). Assays were linear over 3.6-28.8 (artesunate), 5.2-26.0 (dihydroartemisinin) and 5.4-21.6 5g/mL (artemether) with LODs of 0.95, 0.17 and 0.55 μg/mL respectively. Overall recovery of 99.45 ± 2.75 (artesunate), 99.88 ± 2.41 (dihydroartemisinin) and 99.97 ± 1.53% (artemether) were obtained from the three-day assessment of accuracy and repeatability. The procedure was successfully applied to the determination of artemisinin derivatives in tablets and injectables. There was no significant difference (p>0.05) with official methods. The new method has the advantages of speed, cost-effectiveness and simplicity.
Keywords
Artemether; Artesunate; Diazo coupling reaction; Dihydroartemisinin
Tags
PPRTV
•
1,3-Dinitrobenzene 2021
Literature Search June 2021
Scopus (July 2021)
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity